Adaptimmune Therapeutics PLC (ADAPY) income statement
ADAPYOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.04+0.00 (+9.38%)
Close on Oct 19, 2026Market cap $55.46MP/E –Yield –
Adaptimmune Therapeutics PLC financial ratios
See a number that looks wrong?